| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Synd | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treat | Phase III | rekrutiert |
| A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) | Phase III | rekrutiert |
| A Study of Brenipatide in Adult Participants With Major Depressive Disorder | Phase III | rekrutiert |
| A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Muta | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Canc | — | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Mul | Phase II | rekrutiert |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 | Phase III | rekrutiert |
| A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of | Phase III | rekrutiert |
| A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | Phase III | rekrutiert |
| ACT for Mental Health in Neurological Disorders | ohne Phasenangabe | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | Phase II | rekrutiert |
| Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Pa | Phase II / Phase III | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| German-funded Laparoscopic Approach to Cervical Cancer | ohne Phasenangabe | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Intensive-neurofeedback Protocol for Children With ADHD: A Proof-of-concept Study Comparing iAPF | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elev | Phase III | rekrutiert |
| NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometr | — | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderl | ohne Phasenangabe | rekrutiert |
| Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | ohne Phasenangabe | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodul | — | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | — | rekrutiert |
| Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access | — | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared t | Phase III | rekrutiert |
| The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Com | Phase III | rekrutiert |
| The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Tre | Phase IV | rekrutiert |
| Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Partic | Phase II | rekrutiert |
| Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Partici | Phase II | rekrutiert |
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metast | Phase II | rekrutiert |